FREE Account Opening + No Clearing Fees

Moxsh Overseas NSE SME IPO review (Avoid)

Review By Dilip Davda on December 17, 2022

•    MOEL is engaged in offering learning solutions, counselling, and mobility services to students for medical studies. 
•    Its financial performance so far does not match the asking price. 
•    Based on its latest earnings, the issue is aggressively priced. 
•    The company operates in a highly competitive and fragmented segment.
•    There is no harm in skipping this pricy issue.

Moxsh Overseas Educon Ltd. (MOEL) is an Edu-Medi Tech company engaged in the business of offering diverse and cohesive learning solutions, counselling, and mobility services to students aspiring to pursue medical studies (MBBD) in India or abroad under its brand "Moksh". The company also advises students on their medical career planning and execution. MOEL is a digitally native, technology-led business, providing an online learning program for medical entrance examinations, NEET-UG, and for medicos to appear for medical licensing examinations such as USMEL, PLAB, DHA, NeXT, FMGE, etc. under its brand "Moksh Academy". 

As of August 31, 2022, it has a presence across 23 touch points in India, of which it has a presence in 18 cities through franchisee arrangements and with its own 5 offices including a registered office located in Mumbai, Pune, Delhi, Bhopal, and Ahmedabad. During the last three fiscals, it has recruited over 685 students to various foreign medical universities and for healthcare academy services, it served over 580 students. As of the same date, it has 115 employees on its payroll. 

The current disturbing global environment brings more challenges and concern for the prospects of MOEL going forward.

The company is coming out with a maiden IPO of 680800 equity shares of Rs. 10 each at a fixed price of Rs. 153 per share of Rs. 10 each to mobilize Rs. 10.42 cr. The issue opens for subscription on December 21, 2022, and will close on December 23, 2022. The minimum application to be made is for 800 shares and in multiples thereon, thereafter. Post allotment, shares will be listed on NSE SME Emerge. The issue constitutes 30.38% of the post-issue paid-up capital of the company. MOEL is spending Rs. 2.19 cr. for this IPO process. This is indicating for a fully structured process for IPO funding. From the residual funds, the company will spend Rs. 2.50 cr. for working capital, Rs. 3.18 cr. for brand awareness, and Rs. 2.55 cr. for general corporate purposes. 

Fedex Securities Pvt. Ltd. is the sole lead manager and Bigshare Services Pvt. Ltd., is the registrar of the issue. Pure Broking Pvt. Ltd. is the market maker for the company. 

Having issued initial equity shares at par, the company raised further equity shares at the price of Rs. 40 - Rs. 125 per share between May 2020 and April 2022. It has also issued bonus shares in the ratio of 5 for 1 in February 2022, and 3 for 1 in August 2022. The average cost of acquisition of shares by the promoters is Rs. 0.42 per share. 

Post-IPO, MOEL's current paid-up equity capital of Rs. 1.56 cr. will stand enhanced to Rs. 2.24 cr. Based on the IPO pricing, the company is looking for a market cap of Rs. 34.28 cr.  

On the financial performance front, on a consolidated basis, MOEL posted a total income/net profit of Rs. 10.09 cr. / Rs. 1.11 cr. (FY22) and for Q1 of FY23 ended on June 30, 2022, it earned a net profit of Rs. 0.17 cr. on a total income of Rs. 2.28 cr. 

On a standalone basis, for the last three fiscals, MOEL posted a total income/net profit of Rs. 8.18 cr. / Rs. 0.22 cr. (FY20), Rs.3.87 cr. / Rs. 0.05 cr. (FY21), and Rs. 10.09 cr. / Rs. 1.11 cr. (FY22). For Q1 of FY23, it earned a net profit of Rs. 0.18 cr. on a total income of Rs. 2.28 cr. 

For the last three fiscals, MOEL has reported an average EPS of Rs. 4.25 and an average RoNW of 55.87%. The issue is priced at a P/BV of 11.81 based on its NAV of Rs. 12.96 as of June 30, 2022, and at a P/BV of 2.76 based on its post-IPO NAV of Rs. 55.49 per share. 

If we annualize FY23 (consolidated) earnings and attribute it to post-IPO fully diluted paid-up equity capital then the asking price is at a P/E of around 50 and based on FY22 earnings, the P/E comes to 30.91. Thus the issue is aggressively priced discounting all near-term positives. The segment is witnessing high competition and is also fragmented. 

The company has not paid any dividends since its incorporation. It will adopt a prudent dividend policy post-listing, based on its financial performance and future prospects. 

As per the offer document, MOEL has no listed peers to compare with. 

This is the 13th mandate from Fedex Securities in the last three fiscals (including the ongoing one). Out of the last 10 listings, 2 opened at par and the rest with premiums ranging from 0.08% to 108.93% on the date of listing. 

Conclusion / Investment Strategy

The company is in a highly competitive and fragmented segment. Its financial performance so far is not in line with the asking price. Based on its earnings, the issue is aggressively priced. A small equity base post-IPO indicates a longer gestation period for migration to the mainboard. There is no harm in skipping this costly issue.

Reviewer recommends Avoid to the issue.

Review By Dilip Davda on December 17, 2022

Review Author

DISCLAIMER: No financial information whatsoever published anywhere here should be construed as an offer to buy or sell securities, or as advice to do so in any way whatsoever. All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions. My reviews do not cover GMP market and operators game plans. Readers must consult a qualified financial advisor before making any actual investment decisions, based the on information published here. With entry barriers, SEBI wants only well-informed investors to participate in such offers. With crazy listings in the recent past, SME IPOs drew the attention of investors across the board and lead to seer madness. However, as SME issues have entry barriers and continued low preference from the broking community, any reader taking decisions based on any information published here does so entirely at their own risk. The above information is based on information available as of date coupled with market perceptions. The Author has no plans to invest in this offer.

About Dilip Davda

Dilip Davda

Dilip Davda is veteran journalist associated with stock market since 1978. He is contributing to print and electronic media on stock markets/insurance/finance since 1985.

Dilip Davda is a leading reviewer of public issues and NCDs in the primary stock market in India. The knowledge he gained over 3 decades while working in the stock market and a strong relationship with popular lead managers makes his reviews unique. His detail fundamental and financial analysis of companies coming up with IPO helps investors in the primary stock market. Dilip Davda has a special interest in analyzing the SME companies and writing reviews about their public issues. His reviews are regularly published online and in news papers.

(Dilip Davda -SEBI registered Research Analyst-Mumbai,

Registration no. INH000003127 (Perpetual)

Email id: ).

Moxsh Overseas Educon IPO FAQs

  1. 1. Why Moxsh Overseas Educon IPO?

    The initial public offer (IPO) of Moxsh Overseas Educon Limited offers an early investment opportunity in Moxsh Overseas Educon Limited. A stock market investor can buy Moxsh Overseas Educon IPO shares by applying in IPO before Moxsh Overseas Educon Limited shares get listed at the stock exchanges. An investor could invest in Moxsh Overseas Educon IPO for short term listing gain or a long term.

  2. 2. How is Moxsh Overseas Educon IPO?

    Read the Moxsh Overseas Educon IPO recommendations by the leading analyst and leading stock brokers.

  3. 3. Moxsh Overseas Educon IPO what should investors do?

    Moxsh Overseas Educon IPO offers an opportunity to buy IPO shares before they get listed at the stock exchanges. Read the Moxsh Overseas Educon IPO Notes, Analysis and Recommendations by leading stock brokerage firms and experts in the above answer.

  4. 4. Is Moxsh Overseas Educon IPO good?

    Our recommendation for Moxsh Overseas Educon IPO is to avoid.

  5. 5. Is Moxsh Overseas Educon IPO worth Investing?

    As per the analysis by our lead analyst Mr. Dilip Davda, we suggest you to avoid the Moxsh Overseas Educon IPO.

  6. 6. When will Moxsh Overseas Educon IPO allotment status?

    The Moxsh Overseas Educon IPO allotment status will be available on or around December 28, 2022. The allotted shares will be credited in demat account by December 30, 2022. Visit Moxsh Overseas Educon IPO allotment status to check.

  7. 7. When will Moxsh Overseas Educon IPO list?

    The Moxsh Overseas Educon IPO will list on Friday, December 30, 2022, at NSE SME.